SCHEMBL31379283

SCHEMBL31379283

N=C1CC(=O)N2CCCN12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950260 0.81 BRD4 (0.33)
SCHEMBL2514082 0.75 BRD4 (0.33)
SCHEMBL14559892 0.69 BRD4 (0.39)
SCHEMBL12450880 0.64 CHRM2 (0.39)
SCHEMBL600282 0.64 BRD4 (0.52)
SCHEMBL12443428 0.61 BRD4 (0.43)
SCHEMBL1440028 0.61 BRD4 (0.43)
SCHEMBL4475232 0.60 CYP2A6 (0.33)
SCHEMBL2363506 0.60 BRD4 (0.48)
SCHEMBL11382367 0.60 BRD4 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743175-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Aconcagua Bio, Inc. (US) 2026-05-20 EP disclosed
US-20250051355-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO, INC. 2025-02-13 US disclosed
WO-2025015269-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO, INC. (US) 2025-01-16 WO disclosed